Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Vaxcyte, Inc.
  6. Company
    PCVX   US92243G1085

VAXCYTE, INC.

(PCVX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vaxcyte, Inc.
Vaxcyte Inc. is a vaccine company. The Company is focused on developing vaccines designed to prevent or treat common and deadly infectious diseases worldwide. Its cell-free protein synthesis platform enables it to design and produce protein carriers and antigens. Its pipeline includes pneumococcal conjugate vaccine (PCV) candidates. Its lead vaccine candidate is VAX-24, a 24-valent investigational PCV. Its pipeline also includes VAX-XP, VAX-A1 and VAX-PG. The Company's second PCV, VAX-XP, uses its modular platform and builds on the technical proof of concept established by VAX-24. VAX-A1 is a conjugate vaccine being developed for group A strep infections. VAX-PG is being developed as a protein vaccine for the treatment of periodontitis.

Number of employees : 58 people.
Managers
Name Title Age Since
Grant E. Pickering Chief Executive Officer & Director 52 2021
Andrew L. Guggenhime President & Chief Financial Officer 51 2021
Romulo Colindres Chief Medical Officer 49 2020
Jim Wassil Chief Operating Officer 50 2019
Jane Wright-Mitchell Secretary & Chief Compliance Officer 51 2020
Konrad Hans von Emster Chairman 52 2021
K. Peter Hirth, Dr. Independent Director 68 2016
Patrick J. Heron Independent Director 49 2017
Heath Lukatch, Dr. Independent Director 52 2018
Halley E. Gilbert Independent Director 50 2020
Members of the board
Name Title Age Since
Konrad Hans von Emster Chairman 52 2021
Grant E. Pickering Chief Executive Officer & Director 52 2021
K. Peter Hirth, Dr. Independent Director 68 2016
Patrick J. Heron Independent Director 49 2017
Heath Lukatch, Dr. Independent Director 52 2018
Halley E. Gilbert Independent Director 50 2020
Robert L. Hopfner, Dr. Independent Director 47 2017
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 52,189,289 43,540,734 83.4% 0 0.0% 83.4%
Shareholders
NameEquities%
Fidelity Management & Research Co. LLC 7,504,449 14.4%
TPG Group Holdings (SBS) Advisors, Inc. 4,558,475 8.73%
Abingworth LLP 4,168,718 7.99%
Janus Capital Management LLC 4,116,959 7.89%
RA Capital Management LP 3,865,808 7.41%
Longitude Capital Management Co. LLC 3,106,350 5.95%
The Vanguard Group, Inc. 2,791,613 5.35%
Roche Holding AG 2,587,754 4.96%
Frazier Management LLC 2,309,554 4.43%
Medicxi Ventures (Jersey) Ltd. 1,887,478 3.62%
Company contact information
Vaxcyte, Inc.
353 Hatch Drive
Foster City, CA 94404

Phone : +1.650.837.0111
Web : http://www.vaxcyte.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Vaxcyte, Inc.
Sector Bio Therapeutic Drugs
1st jan.Capi. (M$)
VAXCYTE, INC.-3.69%1 324
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
REGENERON PHARMACEUTICALS34.93%67 775
WUXI APPTEC CO., LTD.35.75%60 418
VERTEX PHARMACEUTICALS-20.33%48 850
BEIGENE, LTD.56.02%37 507
GENMAB A/S11.25%27 860
ARGENX SE15.74%16 900
CUREVAC N.V.-32.02%10 301
ASCENDIS PHARMA A/S-3.16%9 180
NEUROCRINE BIOSCIENCES, INC.0.68%9 133
MIRATI THERAPEUTICS, INC.-20.76%8 985
ACCELERON PHARMA INC.7.55%8 380
HUALAN BIOLOGICAL ENGINEERING INC.-33.17%7 965
GW PHARMACEUTICALS PLC89.72%6 907
SAREPTA THERAPEUTICS, INC.-49.33%6 897
FATE THERAPEUTICS, INC.-21.26%6 815
ARROWHEAD PHARMACEUTICALS, INC.-15.38%6 770
ULTRAGENYX PHARMACEUTICAL INC.-29.01%6 666
EXELIXIS, INC.3.24%6 528